Persistent pain in the older adult: What should we do now in light of the 2009 American Geriatrics Society Clinical Practice Guideline?

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 12, 2009, Pages 795-800

  Katz, James D ^a   Shah, Tina ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Nonsteroidal anti inflammatory drugs; Older adults; Persistent pain; Treatment guidelines

Indexed keywords

ACETYLSALICYLIC ACID; BUPRENORPHINE; CAPSAICIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FENTANYL; GLUCOSAMINE; HYALURONIC ACID; INDOMETACIN; KETOPROFEN; LIDOCAINE; MISOPROSTOL; MORPHINE; NALOXONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PLACEBO; ROFECOXIB; TRAMADOL;

ADULT; AVASCULAR NECROSIS; BALANCE IMPAIRMENT; CHRONIC PAIN; CLINICAL TRIAL; CONSTIPATION; DEPIGMENTATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INHIBITION; DRUG SAFETY; GASTROINTESTINAL DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; INFECTION; KIDNEY FAILURE; KNEE PAIN; LOW DRUG DOSE; MEDICAL DOCUMENTATION; NAUSEA; OSTEOARTHRITIS; PAIN; PHYSICIAN; PHYSIOTHERAPY; POSTHERPETIC NEURALGIA; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; STROKE;

EID: 75649110877     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.845     Document Type: Review

References (34)

1. Desai SP, Solomon DH, Abramson SB, et al; American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs. Recommendations for use of selective and non-selective anti-inflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum. 2008; 59: 1058-1073.
2. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2001; 1: 11-21.
3. Singh G. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System. Am J Ther. 2000; 7: 115-121.
4. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009; 57: 1331-1346.
5. Chan FK, Hung LC, Suen BY, et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med. 2002; 347: 2104-2110.
6. Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of anti-platelet therapy and NSAID use: a report of the American College of Cardiology Task Force on clinical expert consensus documents. Circulation. 2008; 118: 1894-1909.
7. Gladding PA, Webster MW, Farrell HB, et al. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers. Am J Cardiol. 2008; 101: 1060-1063.
8. Antman EM, Bennett JS, Daugherty A, et al; American Heart Association. Use of nonsteroidal anti-inflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007; 115: 1634-1642.
9. Baigent C, Patrono C. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal. Arthritis Rheum. 2003; 48: 12-20.
10. Alacqua M, Trifirò G, Cavagna L, et al. Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal. Arthritis Rheum. 2008; 59: 568-574.
11. Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol. 2000; 151: 488-496.
12. Laine L, White WB, Rostom A, Hochberg M. COX-2 selective inhibitors in the treatment of osteoarthritis. Semin Arthritis Rheum. 2008; 38: 165-187.
13. Richy F, Bruyere O, Ethgen O, et al. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis. 2004; 63: 759-766.
14. Pergolizzi J, Böger R, Budd K, et al. Opiods and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opiods (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008; 8: 287-313.
15. Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Critical Care Med. 2008; 36 (Suppl 4): S216-S223.
16. Fine PG. Pharmacological management of persistent pain in older patients. Clin J Pain. 2004; 20: 220-226.
17. Kiltz U, Zochling J, Schmidt WE, Braun J. Use of NSAIDs and infection with Helicobacter pylori - what does the rheumatologist need to know? Rheumatology (Oxford). 2008; 47: 1342-1347.
18. Vlad SC, Miller OR, Kowall NW, Felson DT. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology. 2008; 70: 1672-1677.
19. McKellar G, Madhok R, Singh G. Update on the use of analgesics versus nonsteroidal anti-inflammatory drugs in rheumatic disorders: risks and benefits. Curr Opin Rheumatol. 2008; 20: 239-245.
20. Messier SP, Gutekunst DJ, Davis C, DeVita P. Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis. Arthritis Rheum. 2005; 52: 2026-2032.
21. Ahmad M, Goucke CR. Management strategies for the treatment of neuropathic pain in the elderly. Drugs Aging. 2002; 19: 929-945.
22. Crosby J. Osteoarthritis: managing without surgery. J Fam Pract. 2009; 58: 354-361.
23. Underwood M, Ashby D, Cross P, et al. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ. 2008; 336: 138-142.
24. Biswal S, Medhi B, Pandhi P. Longterm efficacy of topical nonsteroidal antiinflammatory drugs in knee osteoarthritis: meta-analysis of randomized placebo controlled clinical trials. J Rheumatol. 2006; 33: 1841-1844.
25. Zin CS, Nissen LM, Smith MT, et al. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs. 2008; 22: 417-442.
26. Rogojan C, Hetland M. Depigmentation - a rare side effect to intra-articular glucocorticoid treatment. Clin Rheumatol. 2004; 23: 373-375.
27. Bradley JD. Joint irrigation as treatment for osteoarthritis. Curr Rheumatol Rep. 2003; 5: 20-26.
28. Nadstawek J, Leyendecker P, Hopp M, et al. Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain. Int J Clin Pract. 2008; 62: 1159-1167.
29. Vadivelu N, Hines RL. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clin Interv Aging. 2008; 3: 421-430.
30. Sullivan LE, Fiellin DA. Narrative review: buprenorphine for opioid-dependent patients in office practice. Ann Intern Med. 2008; 148: 662-670.
31. White WB. Defining the problem of treating the patient with hypertension and arthritis pain. Am J Med. 2009; 122 (Suppl 5): S3-S9.
32. White WB, Pepine CJ, Weber MA. The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion. Am J Med. 2009; 122 (Suppl 5): S23-S25.
33. Mackenzie IS, Rutherford D, MacDonald TM. Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis. Arthritis Res Ther. 2008; 10 (Suppl 2): S3.
34. Findlay DM. Vascular pathology and osteoarthritis. Rheumatology (Oxford). 2007; 46: 1763-1768.